FEDORKO, Michal, Jaroslav JURÁČEK, Michal STANÍK, Marek SVOBODA, Alexandr POPRACH, Tomáš BÜCHLER, Dalibor PACÍK, Jan DOLEŽEL and Ondřej SLABÝ. Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma. Biochemia Medica. Zagreb: CROATIAN SOC MEDICAL BIOCHEMISTS, vol. 27, No 2, p. 411-417. ISSN 1330-0962. doi:10.11613/BM.2017.043. 2017.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma
Name in Czech Detekce let-7 miRNA v močovém supernatantu jako potenciální způsob diagnostiky nemetastatického karcinomu z renálních buněk
Authors FEDORKO, Michal (703 Slovakia, belonging to the institution), Jaroslav JURÁČEK (203 Czech Republic, belonging to the institution), Michal STANÍK (703 Slovakia), Marek SVOBODA (203 Czech Republic), Alexandr POPRACH (203 Czech Republic), Tomáš BÜCHLER (203 Czech Republic), Dalibor PACÍK (203 Czech Republic, belonging to the institution), Jan DOLEŽEL (203 Czech Republic) and Ondřej SLABÝ (203 Czech Republic, guarantor, belonging to the institution).
Edition Biochemia Medica, Zagreb, CROATIAN SOC MEDICAL BIOCHEMISTS, 2017, 1330-0962.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Croatia
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.653
RIV identification code RIV/00216224:14110/17:00095662
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.11613/BM.2017.043
UT WoS 000404505700018
Keywords (in Czech) karcinom z renálních buněk; močové miRNA; let-7; diagnostický biomarker
Keywords in English renal cell carcinoma; urinary miRNAs; let-7; diagnostic biomarker
Tags EL OK, podil
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 21/3/2018 17:37.
Abstract
Introduction: Urinary microRNAs (miRNAs) are emerging as a clinically useful tool for early and non-invasive detection of various types of cancer. The aim of this study was to evaluate whether let-7 family miRNAs differ in their urinary concentrations between renal cell carcinoma (RCC) cases and healthy controls. Materials and methods: In the case-control study, 69 non-metastatic clear-cell RCC patients and 36 gender/age-matched healthy controls were prospectively enrolled. Total RNA was purified from cell-free supernatant of the 105 first morning urine specimens. Let-7 family miRNAs were determined in cell-free supernatant using quantitative miRNA real-time reverse-transcription PCR and absolute quantification approach. Results: Concentrations of all let-7 miRNAs (let-7a, let-7b, let-7c, let-7d, let-7e and let-7g) were significantly higher in urine samples obtained from RCC patients compared to healthy controls (P < 0.001; P < 0.001; P = 0.005; P = 0.006; P = 0.015 and P = 0.002, respectively). Subsequent ROC analysis has shown that let-7a concentration possesses good ability to differentiate between cases and controls with area under curve being 0.8307 (sensitivity 71%, specificity 81%). Conclusions: We have shown that let-7 miRNAs are abundant in the urine samples of patients with clear-cell RCC, and out of six let-7 family members, let-7a outperforms the others and presents promising non-invasive biomarker for the detection of RCC.
Abstract (in Czech)
MikroRNA v moči jsou potenciálním nástrojem pro časnou a neinvazivní detekci různých typů maligních nádorů. Cílem studie bylo zhodnotit, zda se liší koncentrace miRNA z rodiny let-7 v moči pacientů s renálním karcinomem od zdravých kontrol.
Links
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
NV15-31071A, research and development projectName: Studium močových/tkáňových mikroRNA jako potenciálních biomarkerů uroteliálního karcinomu močového měchýře
NV15-34678A, research and development projectName: Molekulární prognostické a prediktivní faktory u pacientů s metastatickým renálním karcinomem léčených tyrozinkinázovými inhibitory
PrintDisplayed: 18/4/2024 04:34